Market Value1,121,747,000
Total Holdings61
File Date2018-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GWP / GW Pharmaceuticals plc
MRUS / Merus N.V.
PDSB / PDS Biotechnology Corporation
OMED / OptMed Inc
ICPT / Intercept Pharmaceuticals Inc
CNAT / Conatus Pharmaceuticals Inc.
APLS / Apellis Pharmaceuticals, Inc.
OTIC / Otonomy Inc
H03579101 / Auris Medical Holding Ltd
MOLN / Molecular Partners AG
FOLD / Amicus Therapeutics, Inc.
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
ETTX / Entasis Therapeutics Holdings Inc
ADMS / Adamas Pharmaceuticals Inc
ITRM / Iterum Therapeutics plc
TSRO / TESARO, Inc.
BPMC / Blueprint Medicines Corporation
KURA / Kura Oncology, Inc.
OCGN / Ocugen, Inc.
BHVN / Biohaven Ltd.
ESPR / Esperion Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
KDMN / Kadmon Holdings Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
ONCE / Spark Therapeutics, Inc.
US00163U1060 / AMAG Pharmaceuticals, Inc.
EPZM / Epizyme Inc
BOLD / Boundless Bio, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
SPPI / Spectrum Pharmaceuticals, Inc.
FSTX / F-star Therapeutics Inc
PBYI / Puma Biotechnology, Inc.
CALA / Calithera Biosciences, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
US74257L1089 / Principia Biopharma Inc.
US16706W1027 / Chiasma Inc
0HBB / Aimmune Therapeutics Inc
14161H108 / Cardtronics PLC
018490100 / Allergan plc
ANAB / AnaptysBio, Inc.
DERM / Journey Medical Corporation
CLSD / Clearside Biomedical, Inc.
CELG / Celgene Corp.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
ARQL / ArQule, Inc.
KALA / KALA BIO, Inc.
FATE / Fate Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
YMAB / Y-mAbs Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
HRTX / Heron Therapeutics, Inc.
CHRS / Coherus Oncology, Inc.
EXEL / Exelixis, Inc.
OBSV / ObsEva SA.
SNY / Sanofi - Depositary Receipt (Common Stock)
KDNY / Chinook Therapeutics Inc
BLUE / bluebird bio, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
RETA / Reata Pharmaceuticals Inc - Class A
SNDX / Syndax Pharmaceuticals, Inc.
NTRA / Natera, Inc.
PTCT / PTC Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
SVRA / Savara Inc.
RIGL / Rigel Pharmaceuticals, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock) Call
SRPT / Sarepta Therapeutics, Inc.
SYBX / Synlogic, Inc.
CRSP / CRISPR Therapeutics AG Put